Post Profile

Is the FDA Too Cozy With Drug Companies?

A new report look at the "revolving door" between the FDA and drug companies
read more


Related Posts

7 Drugs That Big Pharma Withdrew and Hopes You’ve Forgotten About

News / Independent News : AlterNet

The cozy relationship between the FDA and pharmaceutical companies is resulting in fast-track approval of some dangerous meds. Do you remember the drugs Vioxx, Bextra, Baycol, Trovan, Meridia, Seldane, Hismanal, Darvon, Raxar and Re...

Tell Obama to Drop Monsanto Lobbyist from FDA!

Issues & Causes / Environmentalism : Planetsave

One of the sad things about U.S. government today is the revolving door between industry and politics. Politics is for industry these days, not for the people. One “revolving door poster child” is Michael Taylor. Taylor was a Monsan...

Weiss Smith, Sharfstein; Door Is Open At FDA For Drug Safety And Review

Health : Medical News Today

Too often, people think of the U.S. Food and Drug Administration (FDA) as a huge wall of regulations and don't consider there's an open door in that wall, drug safety scientist Sheila Weiss Smith said Sept. 16 at "Inside the FDA," a...

Brussels ‘Revolving Door’ Keeps Relationship Cozy Between Big Energy and EU Decision Makers

Issues & Causes / Climate Change : DeSmogBlog

The Brussels ‘revolving door’ has allowed Big Energy to remain close to European climate and energy decision makers ahead of December’s Paris COP 21 climate talks, a new report shows. The report, by transparency campaigning and rese...

FDA Considers Whether Naloxone Devices Should Contain Standard Dose of Drug

Addiction / Drug Addiction : Drug Free

The Food and Drug Administration will determine whether naloxone devices distributed in communities should contain a standard dose of the opioid overdose antidote, according to U.S. News & World Report. The post FDA Considers Whethe...


Copyright © 2016 Regator, LLC